Ono Pharmaceutical faces grilling by Full Court in patent extension appeal

Intellectual Property 2021-11-04 9:20 pm By Miklos Bolza | Sydney

Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.